374-6e-migraine-formula-1.jpg (374 6e Migraine Formula 1)
Migraine Formula Tablet, Film Coated
Product Images NDC 41250-374
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Migraine Formula (NDC 41250-374). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Meijer Distribution Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
374-6e-migraine-formula-2.jpg (374 6e Migraine Formula 2)
This is a drug information leaflet for a pain reliever that contains acetaminophen, caffeine, and a nonsteroidal anti-inflammatory drug (NSAID). The leaflet indicates that the product is not suitable for children and teenagers who have chickenpox or flu symptoms. If taken in more than the recommended amount, it can cause severe liver damage. It may also cause stomach bleeding, ringing in the ears or loss of hearing, and allergic reactions. It may also interact with other drugs, so it is essential to consult a doctor before use. The leaflet provides information about dosage, directions, and inactive ingredients. The last section of text appears to be random characters and is not related to the drug information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
